Javier Arranz‐Nicolás

Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals

Javier Arranz‐Nicolás, Jesús Ogando, Denise Soutar et al. · Cancer Immunology Immunotherapy · 2018 · 31 citations · Full text

Signal Transduction, Signaling Pathway, Integral Component +10

Predominant contribution of DGKζ over DGKα in the control of PKC/PDK‐1‐regulated functions in T cells

Antonia Ávila‐Flores, Javier Arranz‐Nicolás, Elena Andrada et al. · Immunology and Cell Biology · 2017 · 29 citations

Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program

Javier Arranz‐Nicolás, Miguel Martin-Salgado, Irene Adán‐Barrientos et al. · Cancer Immunology Immunotherapy · 2021 · 25 citations · Full text

Pd-1-targeted Therapies, Cancer Immunosurveillance, Signal Transduction +9

Diacylglycerol Kinase Malfunction in Human Disease and the Search for Specific Inhibitors

Isabel Mérida, Javier Arranz‐Nicolás, Pedro Torres‐Ayuso et al. · Handbook of experimental pharmacology · 2019 · 16 citations

Specific Inhibitors, Lipid Synthesis, Medicine +8

Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes

Javier Arranz‐Nicolás, Miguel Martin-Salgado, Cristina Rodríguez‐Rodríguez et al. · Journal for ImmunoTherapy of Cancer · 2020 · 15 citations · Full text